VAERS Explorer
Back to explore

Report #2859984

Received Sep 19, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1UNK—

Symptoms (2)

Influenza like illnessMalaise

Symptom narrative

I was very sick; I had a 3-day flu type reaction to the 1st vaccine; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of influenza-like symptoms in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced influenza-like symptoms (Verbatim: I had a 3-day flu type reaction to the 1st vaccine) and sickness (Verbatim: I was very sick). The outcome of the influenza-like symptoms was resolved (duration 3 days) and the outcome of the sickness was not reported. It was unknown if the reporter considered the influenza-like symptoms and sickness to be related to Shingrix. It was unknown if the company considered the influenza-like symptoms and sickness to be related to Shingrix. Additional Information: GSK Receipt Date: 09-SEP-2025 Consumer reported that will not be get the 2nd vaccine.